Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-08-11
1979-10-16
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424 78, 424 80, A61K 920, A61K 3174, A61K 3179
Patent
active
041713770
ABSTRACT:
An ophthalmic solution is provided for the treatment of corneal swelling and the healing of epithelial wounds. The solution is an aqueous solution of tranexamic acid which may contain optionally, other eye-treating ingredients.
REFERENCES:
patent: 3268405 (1966-08-01), Nagasawa et al.
patent: 3574721 (1971-04-01), Melander et al.
patent: 3639626 (1972-02-01), Nagasawa et al.
patent: 3720775 (1973-03-01), Loeffler
patent: 3767789 (1973-10-01), Rankin
patent: 3950405 (1976-04-01), Okano et al.
Chem. Abst. 69, 58299(v) (1968)-Yamasaki et al.
Chem. Abst. 77 14028(s) (1972)-Nakahara.
Acta Opthalmologica (Kbh) 55, 665-673 (1977).
Acta Opthalmologica (Kbh) 56, 121-126 (1978).
Green Keith
Trager Seymour F.
Burton, Parsons & Co., Inc.
Robinson Douglas W.
LandOfFree
Ophthalmic solution of tranexamic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ophthalmic solution of tranexamic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic solution of tranexamic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-805059